Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
Viatris Signs $1.69B M&A Deal with Pacira BioSciences, Inc.
Viatris Inc. has completed its acquisition of Pacira BioSciences, Inc. for approximately $1.69 billion in cash. The transaction was executed via a tender offer for $36.50 per share followed by a merger, establishing Viatris as a leader in non-opioid pain management.
Value
$1.69B
Counterparty
Pacira BioSciences, Inc.
“Today marks an important milestone in the execution of our strategy to strengthen our U.S. innovative medicines business. With Pacira now part of Viatris, we are bringing together complementary portfolios, capabilities and expertise to establish a leadership position in non-opioid pain management. We are excited to welcome our new Pacira colleagues as we create new opportunities to make a meaningful difference for patients and accelerate our path to sustained revenue and earnings growth.”
Procaccianti Hotel REIT announced that its board determined the funding limitation for its Share Repurchase Program (SRP) was reached for the third quarter of 2026. While repurchase requests for deceased stockholders will be honored in full, all other remaining repurchase requests will be prorated at approximately 2.12% due to insufficient net proceeds from the distribution reinvestment plan.
Church & Dwight Co Insider Susan G. Saideman Sells $990K of Stock
Susan G. Saideman sold 8,650 shares of Church & Dwight Co Inc at $114.50 a share, worth $990K in total on Nov 16, 2026. Shares held after the trade: 7,537 (-53.4%).
Pacira BioSciences, Inc. completed its merger with Viatris Inc. on November 17, 2026, following a tender offer where Viatris acquired all outstanding shares for $36.50 per share in cash. As a result of the transaction, Pacira has become a wholly owned subsidiary of Viatris and entered into supplemental indentures to address its outstanding 2.125% Convertible Senior Notes due 2029.
Disney delivered strong FY2026 results with 16% adjusted EPS growth and is pivoting toward a technology-integrated 'One Disney' strategy, prioritizing streaming profitability and massive capacity expansion in experiences.
Algorhythm Holdings reported Q3 2026 financial results, highlighting a 20% revenue increase to $2.1 million and a strategic shift following the acquisition of Azure Energy. The company has ceased funding its unprofitable India-based logistics operations to focus on high-margin renewable power infrastructure advisory services.
“The third quarter was a pivotal period for Algorhythm as we completed the acquisition of Azure Energy and entered the renewable power infrastructure space. We want to emphasize to investors that the Company’s historical results were driven mainly by our transportation business in India, which has generated operating losses. We are taking significant steps to reduce expenses and move away from unprofitable operations. We have stopped funding our transportation business in India and are focusing our investment on activities with the clearest path to high-margin returns. With the acquisition of the Azure business, a strategic advisor to developers of renewable power infrastructure, we have entered the U.S. power infrastructure market. We believe these actions will position the Company to deliver improved shareholder value going forward.”
Greg Smith, Chief Executive Officer of Algorhythm Holdings
Pulmatrix provided a status update on its pending merger with Eos SENOLYTIX, noting that the SEC has declared its Form S-4 registration statement effective and stockholders have approved the deal. The company expects the merger to close by the end of 2026, subject to Nasdaq listing approval and a planned reverse stock split.
Counterparty
Eos SENOLYTIX, Inc.
“Our focus in the third quarter and beyond has been to advance steps towards completing the proposed merger with Eos SENOLYTIX, a privately held biotechnology company developing novel gerotherapeutic peptides targeting mitochondrial dysfunction in aging-related diseases using the MitoXcel™ platform. To that end, we have obtained SEC effectiveness on our registration statement on Form S-4 in relation to the merger as well as approval from our stockholders on the proposed merger. We anticipate closing the proposed merger by the end of the year.”
Peter Ludlum, Interim Chief Executive Officer of Pulmatrix
Edesa Biotech announced that the European Commission has granted orphan designation to its investigational drug paridiprubart for the treatment of Acute Respiratory Distress Syndrome (ARDS). The designation provides regulatory incentives including reduced development fees and potential market exclusivity for up to 10 years following approval.
Olin Corporation provided a status update on its pending merger with Huntsman Corporation, announcing the leadership structure and divisional organization for the combined entity, OlinHuntsman. The company appointed Philip M. Lister as CFO and established a four-division structure (Essential Chemicals, Polyurethanes, Advanced Solutions, and Winchester), with the merger expected to close in the first quarter of 2027.
ConnectM Technology Solutions reported Q3 2026 financial results, its first full quarter following the divestiture of its India operations. Revenue from continuing operations grew 9% year-over-year to $8.9 million, while the company's operating loss improved by 28% to $1.8 million.
Ampco-Pittsburgh Corporation has posted a formal investor presentation to its website and filed it as an exhibit to be used in meetings with existing and prospective investors. The presentation is specifically associated with the IDEAS Conference scheduled for November 18, 2026.
Ranger Gold Corp. remains a shell company with no revenue and a net loss of $12,466 for the six months ended September 30, 2026. The company reported a working capital deficit and an accumulated deficit of $1,236,664, raising substantial doubt about its ability to continue as a going concern.
Integer Holdings M&A Deal with Armstrong Parent, Inc.
Integer Holdings Corporation completed its merger with Armstrong Parent, Inc., an affiliate of KKR, becoming a wholly owned subsidiary. Shareholders of Integer are entitled to receive $127.00 in cash per share. In connection with the closing, the company entered into a new $2.1 billion credit agreement and issued supplemental indentures for its outstanding convertible senior notes.
Ford Motor Company announced that Vice Chair John Lawler will retire effective January 1, 2027, after a career spanning more than 30 years. His responsibilities will be transitioned to other executives, including Awenate Cobbina, Jim Baumbick, and Dave Carroll, and the company does not plan to replace the vice chair role.
Pioneer Power Solutions reported financial results for the third quarter ended September 30, 2026, highlighted by a 41.7% year-to-date increase in backlog to $17.9 million. While the company reported a GAAP operating loss of $2.8 million due to a non-cash software impairment, it achieved non-GAAP operating income of $321,000 and expanded gross margins to 23.1%.
Term
Q3 2026
“Our PRYMUS on-site power system continues to gain traction as customers look for reliable power solutions that can be deployed in months rather than years. Our pipeline of active PRYMUS quotes is now more than $200 million.”
Nathan Mazurek, CEO of Pioneer
“Our third quarter results reflect an improvement in operating performance, even as the timing of certain shipments shifted from the third quarter into the fourth quarter.”
Tomi Environmental Solutions Nasdaq/NYSE Compliance Notice
TOMI Environmental Solutions has regained compliance with Nasdaq's minimum bid price and stockholders' equity requirements, allowing its common stock to continue listing under the symbol 'TOMZ'. The company will be subject to a one-year discretionary monitor by the Nasdaq Hearings Panel beginning September 2, 2026, during which any subsequent noncompliance with equity requirements will result in immediate delisting.
Sprout Social, Inc. appointed Erin Graupmann as Chief Financial Officer, effective November 18, 2026, succeeding interim CFO Ryan Barretto. Her compensation package includes a $450,000 base salary, a 50% target bonus, a $66,250 sign-on bonus, and $4 million in restricted stock units (RSUs) vesting over four years.
Viking Holdings Ltd reported total revenue of $2.18 billion for the three months ended September 30, 2026, compared to $2.00 billion in the prior year period. Net income for the quarter was $498.4 million, a slight decrease from $514.0 million in 2025, while nine-month net income rose to $1.03 billion.
NIKE hosted its 2026 Investor Day to unveil its 'Full Stride Ahead' strategy, focusing on performance sports and sportswear across 23 priority countries. The company established a 2031 financial framework targeting $5 billion in incremental revenue growth and operating margins of 12-14%. Management also committed to returning approximately $12 billion to shareholders through dividends between fiscal 2027 and 2031.
Term
through fiscal 2031
“NIKE is at its best when we start with the athlete and bring the full power of the Company together around sport. Sport has never played a bigger role in people's lives, and as the leader in a growing $330 billion athletic footwear and apparel industry, the opportunity ahead of us has never been greater.”
Elliott Hill, President and Chief Executive Officer of NIKE, Inc.
“We're concentrating our resources where we have the greatest potential to win. We're also changing how we operate — delivering breakthrough products, building deeper local connections and moving faster to capture demand. Together, these actions are designed to return NIKE to sustainable, profitable growth.”
Elliott Hill, President and Chief Executive Officer of NIKE, Inc.
MetaVia announced the completion of the final patient visit in its Phase 1 Part 3A study of DA-1726, a dual GLP-1/glucagon receptor agonist. The company also highlighted interim Part 3B data showing a 68.1% placebo-adjusted reduction in liver fat and 13.5% weight loss, with full data from both parts expected in Q1 2027.
Boxlight Corporation reported Q3 2026 financial results with revenue of $30.1 million and a significant gross margin expansion to 37.1%. The company narrowed its net loss to $1.0 million and improved Adjusted EBITDA to $2.4 million, driven by cost reduction efforts and market share gains for its Clevertouch brand.
Term
Q3 2026
“Our third quarter 2026 results show meaningful improvement across our business. Revenue grew to $30.1 million, gross margin improved to 37.1%, net loss narrowed to $1.0 million from $6.2 million and Adjusted EBITDA increased by $2.8 million to $2.4 million. This improvement is the result of deliberate actions to strengthen gross margin and reduce operating expenses across the company.”
Jennifer Grabow, Interim Chief Financial Officer
“We have also strengthened our balance sheet. We raised $5.5 million of the $7.5 million Series D financing, added a $15 million equity line and reduced our senior secured term loan to $30.0 million. At the same time, Clevertouch gained share to become the No. 4 interactive display brand in North America and No. 5 in EMEA, according to Futuresource Consulting, and our Symphony platform is extending our reach into campus communication and school safety. As schools begin replacing aging classroom displays and other legacy technology, we believe Boxlight is well positioned for growth in 2027 and beyond.”
MAIA Biotechnology reported updated interim efficacy data from Part C of its Phase 2 THIO-101 expansion trial evaluating ateganosine (THIO) in patients with advanced non-small cell lung cancer (NSCLC). The trial demonstrated an 88% disease control rate (DCR) in third-line patients who had progressed after prior immunotherapy and chemotherapy, significantly higher than the 25-35% DCR typically seen with standard chemotherapy.
Aflac Insider Japan Post Holdings Co. Ltd. Sells $2.16M of Stock
Japan Post Holdings Co. Ltd. sold 17,000 shares of Aflac Inc at $127.00 to $127.61 a share (average $127.20) in 2 transactions, worth $2.16M in total on Nov 13, 2026. Shares held after the trade: 50,078,429 (-0.0%).
Nuo Therapeutics reported Q3 2026 financial results with total revenue of $1.9 million, an 80% increase year-over-year. The company highlighted strong growth in hospital-based Aurix sales and noted that final 2027 Medicare reimbursement rulings reinforce its long-term growth outlook.
“As many wound care market participants have commented, the broader wound care space remains unsettled resulting from the dramatic January change to reimbursement economics for skin substitutes/grafts which remained unchanged in the final 2027 rulings mentioned above”
David Jorden, Nuo’s Chief Executive and Financial Officer
“As a business, we are prioritizing both reaching the revenue level required for operational breakeven and assessing opportunities to strengthen our capital structure to support Nuo’s next stage of growth.”
David Jorden, Nuo’s Chief Executive and Financial Officer
Federal Home Loan Bank of Pittsburgh $81M Debt Financing
Federal Home Loan Bank of Pittsburgh committed to issue $81 million in consolidated obligation bonds across six tranches with maturities ranging from 2027 to 2046. These debt securities are joint and several obligations of the eleven Federal Home Loan Banks and are used to fund the bank's operations.
Worthington Enterprises presented at the Baird 2026 Global Industrial Conference in Chicago, providing an overview of its market-leading positions in building, trade, and specialty applications. The company highlighted its long-term financial targets, including a 25% Adjusted EBITDA margin and a 116% free cash flow conversion rate.
Wong Nga Yin Polin resigned as CEO, CFO, Secretary, and Director for personal reasons effective November 14, 2026. Ho Wan Leong was appointed to fill all vacated roles, bringing over 20 years of experience in MedTech, advertising, and capital markets.
ServiceNow delivered a strong Q3 2026 beat, raising AI ACV targets to $1.7 billion while navigating accounting nuances in CRPO and subscription revenue due to strategic deployment investments.
MongoDB, Inc. has acquired Firebolt Analytics Inc. to integrate its high-performance analytics engine into the MongoDB Intelligent Data Platform. The acquisition aims to enable real-time analytics on live operational data without the need for separate data pipelines, supporting applications and AI agents that require sub-second query responses.
Lineage Cell Therapeutics President and CEO Brian M. Culley Buys $37.1K of Stock
Brian M. Culley, President and CEO, bought 40,500 shares of Lineage Cell Therapeutics, Inc. at $0.916 a share, worth $37.1K in total on Nov 16, 2026. Shares held after the trade: 296,016 (+15.9%).